- Home
- CLDX vs EWTX Comparison
CLDX vs EWTX Comparison
Compare CLDX & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- EWTX
- Stock Information
- Founded
- CLDX 1983
- EWTX 2017
- Country
- CLDX United States
- EWTX United States
- Employees
- CLDX N/A
- EWTX N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLDX Health Care
- EWTX Health Care
- Exchange
- CLDX Nasdaq
- EWTX Nasdaq
- Market Cap
- CLDX 2.9B
- EWTX 3.3B
- IPO Year
- CLDX 2008
- EWTX 2021
- Fundamental
- Price
- CLDX $23.55
- EWTX $31.44
- Analyst Decision
- CLDX Buy
- EWTX Strong Buy
- Analyst Count
- CLDX 8
- EWTX 5
- Target Price
- CLDX $64.83
- EWTX $40.40
- AVG Volume (30 Days)
- CLDX 1.1M
- EWTX 719.8K
- Earning Date
- CLDX 11-06-2024
- EWTX 11-07-2024
- Dividend Yield
- CLDX N/A
- EWTX N/A
- EPS Growth
- CLDX N/A
- EWTX N/A
- EPS
- CLDX N/A
- EWTX N/A
- Revenue
- CLDX $9,976,000.00
- EWTX N/A
- Revenue This Year
- CLDX N/A
- EWTX N/A
- Revenue Next Year
- CLDX N/A
- EWTX N/A
- P/E Ratio
- CLDX N/A
- EWTX N/A
- Revenue Growth
- CLDX 128.55
- EWTX N/A
- 52 Week Low
- CLDX $23.49
- EWTX $5.93
- 52 Week High
- CLDX $53.18
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- CLDX 29.53
- EWTX 43.30
- Support Level
- CLDX $25.56
- EWTX $34.39
- Resistance Level
- CLDX $28.15
- EWTX $38.12
- Average True Range (ATR)
- CLDX 1.62
- EWTX 1.87
- MACD
- CLDX 0.14
- EWTX -0.74
- Stochastic Oscillator
- CLDX 1.27
- EWTX 0.89
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.